Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Results 1 - 5 of 5 for Teplizumab
  1. Teplizumab-mzwv injection 
    Teplizumab-mzwv injection is used to slow the progression of Stage 2 Type 1 Diabetes Mellitus (T1DM) ... adults and children age 8 years and older. Teplizumab-mzwv is in a class of medications called ...
    https://medlineplus.gov/druginfo/meds/a622077.html - Drugs and Supplements
  2. Drug Delays Onset of Type 1 Diabetes From the National Institutes of Health (National Institutes of Health)  
    A study found that the drug teplizumab helped people at risk for type 1 diabetes. The drug delayed the average time to the start of the disease. Some who ...
    https://newsinhealth.nih.gov/.../drug-delays-onset-type-1-diabetes - External Health Links
  3. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury From the National Institutes of Health (National Library of Medicine) (National Institute of Diabetes and Digestive and Kidney Diseases)  
    Liver Diseases/Statistics and Research ... Liver Diseases ... Medicines/Statistics and Research ... Medicines ... National Library of Medicine ... National Institute of Diabetes ...
    https://www.ncbi.nlm.nih.gov/books/NBK547852 - External Health Links
  4. LactMed: Drugs and Lactation Database From the National Institutes of Health (National Library of Medicine)  
    Breastfeeding/Statistics and Research ... Breastfeeding ... National Library of Medicine ... From the National Institutes of Health ... The LactMed® database contains information ...
    https://www.ncbi.nlm.nih.gov/books/NBK501922 - External Health Links
  5. New drug may slow or prevent type 1 diabetes | NIH MedlinePlus Magazine 
    ... people in the study were given the drug, teplizumab, and half took a placebo, which doesn't ... showed improved insulin production. If it is approved, teplizumab would be the first drug to delay or ...
    https://magazine.medlineplus.gov/...-slow-or-prevent-type-1-diabetes - MedlinePlus Magazine